Simmaron Simmaron Research R&D lab's scientist Sarojini is presenting at NIH SPARK ME symposium. Avik Roy Gunnar Gottschalk NIH

#longcovid #mecfs Gunnar Gottschalk

Just 1 week until #GivingTuesday! If you can give, fund a 1st in #MECFS: a treatment trial designed around a biomarker. We invite everyone to follow our ground-breaking work to spur #ME treatment trials. Patients have waited too long. #POTS #Longcovid simmaronresearch.com/donate

On #GivingTuesday, fund a groundbreaking treatment trial for #MECFS! Our Rapamycin pilot trial is designed on a biomarker that we found in an #ME patient subset. That’s new! Testing of ATG13 is a big part of trial costs. You can help! #longcovid #POTS simmaronresearch.com/donate

So excited to be working with this great clinical team! #MECFS #ME Avik Roy

Lots of work and more to come! Please consider a donation to help fund our group! Avik Roy Simmaron Research #MECFS #LongCovid

So excited (slightly overwhelmed )with the response from patients who want to participate in our trial! I am doing my best to get back to everyone. We’re underway at 3 sites. Thank you to all. Help fund Simmaron Research for #GivingTuesday Avik Roy

Now our Simmaron Research Gunnar Gottschalk preprint is out that demonstrates why tetrahydrobiopterin biosnthesis is upregulated in ME+OI pathogenesis. researchsquare.com/article/rs-371…

New paper! Great work by the Simmaron team!

The entire Simmaron team Simmaron Research is attending the annual meeting on ME/CFS at NIH. It is a proud moment for us to be mentioned by the director of NINDS NIH Gunnar Gottschalk

Thank you Walter J. Koroshetz and NINDS for hosting such a great conference. Great presentations and fun to catch up with some of the best mentors like Dr. Lipkin Center for Infection & Immunity Simmaron Research Avik Roy #MECFS

I am so happy to see Molly highlighted by UW-Milwaukee for her extremely important work with Simmaron Research. She is a rock star! uwm.edu/letters-scienc…

Simmaron Research Simmaron Research INC has launched a nationwide clinical trial on Rapamycin in the amelioration of ME/CFS pathogenesis. It is an observational pilot trial.Gunnar Gottschalk Solve ME/CFS Initiative classic.clinicaltrials.gov/ct2/show/NCT06…

I feel honored to be selected as a member of MIDD. This collaboration will facilitate Simmaron Research to design, discover, and develop small molecular therapeutics in chronic neuroiflammatory and other metabolic diseases. uwm.edu/drug-discovery…

Just recently, Dr. Roy was awarded a competitive R21 grant from the NIH to study ATG13: A new player in ME/CFS. This grant will fund his ground-breaking work in autophagy in ME/CFS. Dr. Roy is an Adjunct Professor of the Department of Chemistry and Biochemistry. Simmaron Research

Huge congrats to Molly Drosen and Amy Reyes for taking 1st and 2nd place presenting their posters describing key mechanisms underlying ME/CFS at the UWM annual chemistry symposium! Great mentorship from Avik Roy!! UW-Milwaukee Simmaron Research Avik Roy

Help us welcome a new clinician to the growing list of participating doctors in our rapamycin trial: Jennifer Bell, APRN, FNP, at Bateman Horne Center! See our full list of participating clinicians on our website: simmaronresearch.com/rapamycin-trial

Please check out Simmaron's newest publication here! Thank you to all of the patients and our supporters! doi.org/10.1177/117957… “Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway”

Dr. Avik Roy & co-authors examine orthostatic imbalance in people w/ #MECFS using an interesting new experimental model to dissect the metabolic missteps responsible for this effect. Read our summary of the Solve-funded study: ow.ly/PNCN50T85pk #MEAwarenessHour